These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 38194088

  • 21. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
    Hamadeh F, Awadallah A, Meyerson HJ, Beck RC.
    Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
    [Abstract] [Full Text] [Related]

  • 22. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
    Liao C, Hu NX, Song H, Zhang JY, Shen DY, Xu XJ, Tang YM.
    Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
    [Abstract] [Full Text] [Related]

  • 23. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS, Lemmert K, Enjeti A.
    BMJ Case Rep; 2016 Jan 20; 2016():. PubMed ID: 26791132
    [Abstract] [Full Text] [Related]

  • 24. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
    Hwang K, Park CJ, Jang S, Chi HS, Huh JR, Lee JH, Suh C, Lee KH.
    Histopathology; 2013 Apr 20; 62(5):764-70. PubMed ID: 23470050
    [Abstract] [Full Text] [Related]

  • 25. [Blastic plasmacytoid dendritic cell neoplasm (BPDCN) : A rare hematologic neoplasm with frequent cutaneous involvement].
    Nguyen K, Korsing S, Mansour Y, Meier K.
    Dermatologie (Heidelb); 2023 Oct 20; 74(10):787-792. PubMed ID: 37407876
    [Abstract] [Full Text] [Related]

  • 26. Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
    Economides MP, Rizzieri D, Pemmaraju N.
    Curr Hematol Malig Rep; 2019 Dec 20; 14(6):515-522. PubMed ID: 31853773
    [Abstract] [Full Text] [Related]

  • 27. A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients.
    Gong C, Liu Y, Zhang M.
    Ther Adv Hematol; 2024 Dec 20; 15():20406207241251602. PubMed ID: 38832237
    [Abstract] [Full Text] [Related]

  • 28. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
    Ding Y, Yang J, Lindsey K.
    Diagn Cytopathol; 2021 Feb 20; 49(2):E80-E83. PubMed ID: 32852895
    [Abstract] [Full Text] [Related]

  • 29. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
    Rauh MJ, Rahman F, Good D, Silverman J, Brennan MK, Dimov N, Liesveld J, Ryan DH, Burack WR, Bennett JM.
    Leuk Res; 2012 Jan 20; 36(1):81-6. PubMed ID: 21890199
    [Abstract] [Full Text] [Related]

  • 30. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
    Pagano L, Valentini CG, Grammatico S, Pulsoni A.
    Br J Haematol; 2016 Jul 20; 174(2):188-202. PubMed ID: 27264021
    [Abstract] [Full Text] [Related]

  • 31. Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023.
    Pemmaraju N, Kantarjian H.
    Clin Adv Hematol Oncol; 2023 May 20; 21(5):257-264. PubMed ID: 37145496
    [Abstract] [Full Text] [Related]

  • 32. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC, Kim J, Natkunam Y, Sundram U, Freud AG, Gammon B, Cascio MJ.
    Am J Surg Pathol; 2016 Apr 20; 40(4):502-9. PubMed ID: 26796502
    [Abstract] [Full Text] [Related]

  • 33. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
    Wu SJ, Sadigh S, Lane AA, Pinkus GS.
    Am J Clin Pathol; 2023 May 02; 159(5):455-463. PubMed ID: 36880313
    [Abstract] [Full Text] [Related]

  • 34. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Khoury JD.
    Curr Hematol Malig Rep; 2018 Dec 02; 13(6):477-483. PubMed ID: 30350260
    [Abstract] [Full Text] [Related]

  • 35. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
    Ahogo KC, Wantz M, Cliquennois M, Gosset P, Lebas D, Modiano P.
    Ann Dermatol Venereol; 2014 Jan 02; 141(1):43-7. PubMed ID: 24461094
    [Abstract] [Full Text] [Related]

  • 36. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
    Paluri R, Nabell L, Borak S, Peker D.
    Hematol Oncol; 2015 Dec 02; 33(4):206-11. PubMed ID: 24850172
    [Abstract] [Full Text] [Related]

  • 37. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics.
    Adimora IJ, Wilson NR, Pemmaraju N.
    Cancer; 2022 Aug 15; 128(16):3019-3026. PubMed ID: 35726525
    [Abstract] [Full Text] [Related]

  • 38. Blastic plasmacytoid dendritic cell neoplasm: A clinicopathological diagnostic dilemma report of three cases with review of literature.
    Purkait S, Gupta S, Bakhshi S, Mallick S.
    J Cancer Res Ther; 2022 Dec 15; 18(Supplement):S471-S474. PubMed ID: 36511007
    [Abstract] [Full Text] [Related]

  • 39. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
    Cronin DM, George TI, Reichard KK, Sundram UN.
    Am J Clin Pathol; 2012 Mar 15; 137(3):367-76. PubMed ID: 22338048
    [Abstract] [Full Text] [Related]

  • 40. Tagraxofusp, a first-in-class CD123-targeted agent: Five-year postapproval comprehensive review of the literature.
    Jen WY, Konopleva M, Pemmaraju N.
    Cancer; 2024 Jul 01; 130(13):2260-2271. PubMed ID: 38620053
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.